You have 9 free searches left this month | for more free features.

ESBL-E

Showing 1 - 25 of 3,535

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Developing Microbials to Fight Extended-spectrum

Active, not recruiting
  • Extended Spectrum Beta Lactamases (ESBL) E. Coli
  • examination of stool sample
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Clinical Microbiology
Aug 3, 2021

Intensive Care Unit Acquired Infections in Patients Colonized

Not yet recruiting
  • Ventilator Associated Pneumonia
  • +3 more
  • observational
  • Brest, France
    CHRU de Brest
May 25, 2021

Enterobacteriaceae Infections Trial in Bayonne, Bordeaux (Piperacillin-tazobactam)

Not yet recruiting
  • Enterobacteriaceae Infections
  • Bayonne, France
  • +1 more
Jun 4, 2021

Perinatal Transmission of MDR Bacteria

Recruiting
  • E. Coli Infection
  • Multi-antibiotic Resistance
    • Chicago, Illinois
      Prentice Women's Hospital
    Nov 20, 2023

    Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)

    Withdrawn
    • Bacteremia Caused by Gram-Negative Bacteria
    • Newcastle, New South Wales, Australia
    • +28 more
    May 17, 2022

    Organ Failure, Multiple Trial (FTIR results)

    Not yet recruiting
    • Organ Failure, Multiple
    • FTIR results
    • (no location specified)
    May 22, 2023

    Recurrent Urinary Tract Infection Trial in Helsinki (Feacal microbial transplantation (FMT), Placebo transplantation (PT))

    Recruiting
    • Recurrent Urinary Tract Infection
    • Feacal microbial transplantation (FMT)
    • Placebo transplantation (PT)
    • Helsinki, Finland
      Meilahti Vaccine Research Center, Helsinki University Central Ho
    Sep 15, 2023

    ESBL-E Colonisation and Subsequent ESBL-E Infection

    Unknown status
    • Extended Spectrum Beta-Lactamase Producing Bacteria Infection
    • +2 more
    • ESBL-E fecal carriage screening according to routine care
    • Bordeaux, Nouvelle-Aquitaine, France
      Medical intensive care unit, Pelelgrin hospital
    Oct 17, 2019

    Enterobacteria Infections Trial in Paris, Bobigny, Corbeil-Essonnes (Control (Patients colonized rectally with ESBL-producing

    Recruiting
    • Enterobacteria Infections
    • Control (Patients colonized rectally with ESBL-producing enterobacteria without antibiotic pressure)
    • Case (Patients colonized rectally with ESBL-producing enterobacteriaceae, with antibiotic pressure)
    • Paris, Groupe Hospitalier Paris Saint-Joseph, France
    • +3 more
    Aug 17, 2022

    Multidrug Resistant Organisms, Faecal Microbiota Transplantation Trial in Hvidovre (Faecal microbiota transplantation, Placebo)

    Not yet recruiting
    • Multidrug Resistant Organisms
    • Faecal Microbiota Transplantation
    • Faecal microbiota transplantation
    • Placebo
    • Hvidovre, Copenhagen, Denmark
      Hvidovre Hospital, Copenhagen University
    Feb 27, 2023

    Reservoirs, Vehicles and Transmission of ESBL-producing

    Completed
    • Resistance Bacterial
    • Enterobacteriaceae Infections
    • ESBL-producing enterobacteriaceae carriage
    • Besançon, Bourgogne Franche-Comté, France
      University Hospital
    Feb 23, 2022

    Temocillin in ESBL-Enterobacteriaceae Infections

    Not yet recruiting
    • Infectious Disease
    • Temocillin
    • (no location specified)
    Jun 7, 2022

    Household Transmission Dynamics of Multidrug Resistant

    Not yet recruiting
    • Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
      • (no location specified)
      Apr 3, 2023

      Transmission of ESBL-producing Enterobacteriaceae

      Recruiting
      • Hospital Acquired Infection
      • ESBL-producing Enterobacteriaceae
      • Basel, Switzerland
        University Hospital Switzerland, Division of Infecteous Disease
      Oct 10, 2022

      Urinary Tract Infections, Transplant-Related Disorder Trial in Tehran (Phage)

      Recruiting
      • Urinary Tract Infections
      • Transplant-Related Disorder
      • Phage
      • Tehran, Iran, Islamic Republic of
        Nooshin Dalili
      Jul 21, 2023

      Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection Trial (Pivmecillinam and amoxicillin/clavulanic acid,

      Not yet recruiting
      • Urinary Tract Infections
      • +2 more
      • Pivmecillinam and amoxicillin/clavulanic acid
      • Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility
      • (no location specified)
      Nov 18, 2022

      Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC

      Recruiting
      • Enterobacteriaceae Infections
        • Antananarivo, Madagascar
          Institut Pasteur de Madagascar
        Aug 30, 2021

        Enterobacteriaceae Infections, Fecal Microbiota Transplantation Trial in France (Fecal Microbiota Transplantation (FMT)

        Not yet recruiting
        • Enterobacteriaceae Infections
        • Fecal Microbiota Transplantation
        • Fecal Microbiota Transplantation (FMT) capsules
        • Placebo capsules
        • Clichy, France
        • +10 more
        Aug 2, 2022

        Imipenem and Meropenem on Digestive Microbiota and Emergence and

        Not yet recruiting
        • Enterobacteriaceae Infections
          • Bobigny, France
          • +1 more
          Aug 23, 2022

          Research of Consequences on Digestive Tract Following Proposed

          Recruiting
          • Urinary Tract Infections
          • Urinary Tract Infections in Children
          • Amikacin
          • usual antibiotic treatment
          • Clamart, Ile-de France, France
          • +19 more
          Jan 25, 2023

          Colonization With Resistant Enterobacterales in Neutropenic

          Completed
          • Hematologic Malignancy
          • +3 more
          • No intervention.
          • San Francisco, California
          • +5 more
          Apr 5, 2022

          Temocillin Versus Carbapenems for Urinary Tract Infection Due to

          Completed
          • Urinary Tract Infection Bacterial
          • Any intervention
          • (no location specified)
          Dec 11, 2020

          Infection, Hospital Trial (Discontinuation of contact precautions for ESBLE)

          Not yet recruiting
          • Infection, Hospital
          • Discontinuation of contact precautions for ESBLE
          • (no location specified)
          Jul 25, 2022

          Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin

          Active, not recruiting
          • Klebsiella Infections
            • Paris, France
              Groupe Hospitalier Paris Saint-Joseph
            Dec 31, 2021

            Antimicrobial Resistance in Hospitals From Meta, Colombia

            Not yet recruiting
            • Increased Drug Resistance
            • Factors associated
            • Villavicencio, Meta, Colombia
              Hospital Departamental de Villavicencio
            Sep 16, 2023